Proteomics for drug target discovery
- 1 September 2004
- journal article
- Published by Elsevier in Chemometrics and Intelligent Laboratory Systems
- Vol. 73 (1) , 47-53
- https://doi.org/10.1016/j.chemolab.2003.11.011
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator‐activated receptor activatorsProteomics, 2003
- Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteinsMolecular Brain Research, 2002
- Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsyMovement Disorders, 2002
- Preimplantation genetic diagnosis for single gene disorders: experience with five single gene disordersPrenatal Diagnosis, 2002
- Proteome analysis of cerebrospinal fluid proteins in Alzheimer patientsNeuroReport, 2002
- A one-bead, one-stock solution approach to chemical genetics: part 1Chemistry & Biology, 2001
- A one-bead, one-stock solution approach to chemical genetics: part 2Chemistry & Biology, 2001
- One-Carbon Metabolism and Other Biochemical Correlates of Cognitive Impairment as Visualized by Principal Component AnalysisJournal of Geriatric Psychiatry and Neurology, 2001
- Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese miceJournal of Lipid Research, 1999
- A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643Electrophoresis, 1999